论文信息 - Abstract LB-127: From bench to bedside: Exploring OX40 receptor modulation in a phase 1/2a study of the OX40 costimulatory agonist BMS-986178 ± nivolumab (NIVO) or ipilimumab (IPI) in patients with advanced solid tumors - 字舞流文

Abstract LB-127: From bench to bedside: Exploring OX40 receptor modulation in a phase 1/2a study of the OX40 costimulatory agonist BMS-986178 ± nivolumab (NIVO) or ipilimumab (IPI) in patients with advanced solid tumors

Robert J. Neely | D. Greenawalt | A. Klippel | M. Quigley | Nataly Manjarrez-Orduño | M. Hedrick | Yongliang Sun | Rui Wang | Chan Gao | Ed Hilt | I. Pak | Yan Feng | P. Aanur | Xiling Yuan | R. Anand | Katherine S. Yang | Z. Cao | B. Penhallow | Goce Bogdanoski | X. Shao | M. D'silva